SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-24-093404
Filing Date
2024-04-11
Accepted
2024-04-11 17:27:59
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d173394ddefa14a.htm DEFA14A 11040
2 GRAPHIC g173394g04g04.jpg GRAPHIC 268713
3 GRAPHIC g173394g05g05.jpg GRAPHIC 207972
  Complete submission text file 0001193125-24-093404.txt   668929
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33137 | Film No.: 24839475
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)